Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €7.67 EUR
Change Today +0.216 / 2.90%
Volume 3.2K
APS On Other Exchanges
As of 2:21 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Timothy P. Clackson Ph.D.

President of Research & Development and Chief Scientific Officer, Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Dr. Timothy P. Clackson, also known as Tim, Ph.D. has been Chief Scientific Officer of ARIAD Pharmaceuticals Inc. on September 30, 2003 and has been its President of Research and Development since June 2010. Dr. Clackson served as Senior Vice President, Science and Technology of Ariad Pharmaceuticals Inc. from June 2002. Previously, Dr. Clackson served as Vice President, Gene Therapy and Genomics of ARIAD Pharmaceuticals, Inc. from June 2000 to June 2002, as Director, ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.


University of Cambridge
University of Oxford

Other Affiliations*

Annual Compensation*

Total Annual Compensation$492,423

Stock Options*

Restricted Stock Awards$678,925
All Other Compensation$31,979
Exercised Options57,939
Exercised Options Value$881,430
Exercisable Options185,150
Exercisable Options Value$305,613
Unexercisable Options152,333
Unexercisable Options Value$35,700
Total Value of Options$1,222,742
Total Number of Options395,422

Total Compensation*

Total Annual Cash Compensation$524,402
Total Short Term Compensation$492,423
Other Long Term Compensation$710,904
Total Calculated Compensation$2,055,276
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APS:GR €7.67 EUR +0.216


Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
Aijaz Tobaccowalla Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee
Pfizer Limited
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at